tiprankstipranks
Shivalik Rasayan Ltd (IN:SHIVALIK)
:SHIVALIK
India Market

Shivalik Rasayan Ltd (SHIVALIK) AI Stock Analysis

0 Followers

Top Page

IN:SHIVALIK

Shivalik Rasayan Ltd

(SHIVALIK)

Select Model
Select Model
Select Model
Neutral 54 (OpenAI - 5.2)
Rating:54Neutral
Price Target:
₹279.00
▼(-22.23% Downside)
Action:ReiteratedDate:03/26/26
The score is primarily supported by solid revenue growth and a strengthening equity base, but it is held back by weak cash flow quality and deteriorating net margin trends. Technical indicators also point to a sustained downtrend, and valuation looks demanding given the high P/E and very low dividend yield.
Positive Factors
Revenue Growth Trend
Sustained top-line growth over multiple years indicates steady demand for the company’s chemical intermediates and specialty products. This durable revenue expansion supports scale economics, repeat customer relationships and the capacity to reinvest in production or product development over the next several quarters.
Negative Factors
Negative Operating & Free Cash Flow
Persistent negative operating and free cash flow is a structural concern: it limits the firm’s ability to fund working capital, capex or deleverage internally. Over a multi-quarter horizon this forces reliance on external financing or equity and increases vulnerability to interest rate or liquidity stress.
Read all positive and negative factors
Positive Factors
Negative Factors
Revenue Growth Trend
Sustained top-line growth over multiple years indicates steady demand for the company’s chemical intermediates and specialty products. This durable revenue expansion supports scale economics, repeat customer relationships and the capacity to reinvest in production or product development over the next several quarters.
Read all positive factors

Shivalik Rasayan Ltd (SHIVALIK) vs. iShares MSCI India ETF (INDA)

Shivalik Rasayan Ltd Business Overview & Revenue Model

Company Description
Shivalik Rasayan Ltd. engages in the manufacture of pharmaceutical and agrochemical products. Its products include organophosphorous based insecticides and chemicals. The company was founded by Rahul Bishnoi on March 16, 1979 and is headquartered ...
How the Company Makes Money
Shivalik Rasayan Ltd primarily makes money by selling chemical products it manufactures (chemical intermediates and specialty chemicals) to customers, with revenue recognized from product sales. Key drivers typically include volumes sold, product ...

Shivalik Rasayan Ltd Financial Statement Overview

Summary
Strong revenue growth and generally stable EBIT/EBITDA margins support profitability, and equity has strengthened. However, net margin has weakened recently and persistent negative operating/free cash flow is a meaningful risk to financial quality.
Income Statement
75
Positive
Balance Sheet
70
Positive
Cash Flow
60
Neutral
BreakdownTTMMar 2025Mar 2024Mar 2023Mar 2022Mar 2021
Income Statement
Total Revenue3.38B3.12B2.73B2.34B2.07B1.96B
Gross Profit1.30B805.70M1.33B1.20B533.21M680.77M
EBITDA503.80M485.11M461.64M493.13M534.26M411.80M
Net Income140.50M166.96M127.17M212.35M256.06M176.02M
Balance Sheet
Total Assets8.04B7.34B6.92B5.78B4.88B3.63B
Cash, Cash Equivalents and Short-Term Investments468.39M279.69M377.38M306.71M707.58M47.73M
Total Debt1.00B938.83M859.67M655.12M411.22M301.48M
Total Liabilities2.18B1.98B1.85B1.59B1.24B1.03B
Stockholders Equity5.87B5.36B3.90B3.10B2.87B1.79B
Cash Flow
Free Cash Flow-267.77M-294.37M-757.31M-821.81M-138.32M-64.92M
Operating Cash Flow-168.43M-86.05M-80.75M-189.49M111.34M587.69M
Investing Cash Flow-157.64M-208.31M-743.08M-707.72M-233.56M-790.95M
Financing Cash Flow514.76M196.69M894.49M496.34M782.07M19.83M

Shivalik Rasayan Ltd Technical Analysis

Technical Analysis Sentiment
Neutral
Last Price358.75
Price Trends
50DMA
273.69
Negative
100DMA
322.81
Negative
200DMA
407.59
Negative
Market Momentum
MACD
-6.00
Negative
RSI
53.24
Neutral
STOCH
77.92
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IN:SHIVALIK, the sentiment is Neutral. The current price of 358.75 is above the 20-day moving average (MA) of 246.69, above the 50-day MA of 273.69, and below the 200-day MA of 407.59, indicating a neutral trend. The MACD of -6.00 indicates Negative momentum. The RSI at 53.24 is Neutral, neither overbought nor oversold. The STOCH value of 77.92 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for IN:SHIVALIK.

Shivalik Rasayan Ltd Peers Comparison

Overall Rating
UnderperformOutperform
Sector (61)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
69
Neutral
₹7.03B17.610.81%33.39%85.08%
62
Neutral
₹10.93B17.660.52%28.67%50.12%
61
Neutral
$10.43B7.12-0.05%2.87%2.86%-36.73%
57
Neutral
₹9.24B8.7423.32%447.31%
56
Neutral
₹8.15B697.5115.56%2114.71%
54
Neutral
₹4.18B51.210.13%13.17%-0.02%
49
Neutral
₹7.53B-10.640.39%
* Basic Materials Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
IN:SHIVALIK
Shivalik Rasayan Ltd
265.55
-344.47
-56.47%
IN:BHAGERIA
Bhageria Industries Ltd.
161.15
1.38
0.86%
IN:BODALCHEM
Bodal Chemicals Limited
64.75
-2.27
-3.39%
IN:HERANBA
Heranba Industries Limited
192.65
-45.97
-19.26%
IN:SHREEPUSHK
Shree Pushkar Chemicals & Fertilisers Ltd.
338.10
90.76
36.69%
IN:ZUARI
Zuari Agro Chemicals Ltd.
219.80
1.05
0.48%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Mar 26, 2026